Suppr超能文献

陆生生物源抗菌剂在医学应用中的最新进展。

Recent Progress in Terrestrial Biota Derived Antibacterial Agents for Medical Applications.

机构信息

Department of Polymer Engineering, University of Chemical Technology and Metallurgy, 8 "Kl. Ohridski" Blvd, 1756 Sofia, Bulgaria.

Andalusian Center of Developmental Biology, CSIC, Junta de Andalusia, University of Pablo de Olavide, 41013 Seville, Spain.

出版信息

Molecules. 2024 Oct 15;29(20):4889. doi: 10.3390/molecules29204889.

Abstract

Conventional antibiotic and multidrug treatments are becoming less and less effective and the discovery of new effective and safe antibacterial agents is becoming a global priority. Returning to a natural antibacterial product is a relatively new current trend. Terrestrial biota is a rich source of biologically active substances whose antibacterial potential has not been fully utilized. The aim of this review is to present the current state-of-the-art terrestrial biota-derived antibacterial agents inspired by natural treatments. It summarizes the most important sources and newly identified or modified antibacterial agents and treatments from the last five years. It focuses on the significance of plant- animal- and bacteria-derived biologically active agents as powerful alternatives to antibiotics, as well as the advantages of utilizing natural antibacterial molecules alone or in combination with antibiotics. The main conclusion is that terrestrial biota-derived antibacterial products and substances open a variety of new ways for modern improved therapeutic strategies. New terrestrial sources of known antibacterial agents and new antibacterial agents from terrestrial biota were discovered during the last 5 years, which are under investigation together with some long-ago known but now experiencing their renaissance for the development of new medical treatments. The use of natural antibacterial peptides as well as combinational therapy by commercial antibiotics and natural products is outlined as the most promising method for treating bacterial infections. In vivo testing and clinical trials are necessary to reach clinical application.

摘要

传统的抗生素和多药治疗方法的效果越来越差,发现新的有效和安全的抗菌剂已成为全球的当务之急。回归天然抗菌产品是一个相对较新的当前趋势。陆地生物群是生物活性物质的丰富来源,其抗菌潜力尚未得到充分利用。本综述旨在介绍受天然疗法启发的最新陆地生物群衍生的抗菌剂。它总结了过去五年中最重要的来源以及新鉴定或修饰的抗菌剂和治疗方法。它侧重于植物、动物和细菌衍生的生物活性物质作为抗生素替代品的重要性,以及单独或与抗生素联合使用天然抗菌分子的优势。主要结论是,陆地生物群衍生的抗菌产品和物质为现代改良治疗策略开辟了多种新途径。在过去的 5 年中,发现了陆地生物群中已知抗菌剂的新来源和新的抗菌剂,这些物质正在与一些早已发现但现在因开发新的医疗方法而重新受到关注的物质一起进行研究。使用天然抗菌肽以及商业抗生素和天然产品的组合疗法被概述为治疗细菌感染最有前途的方法。需要进行体内测试和临床试验才能达到临床应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e32/11510244/bc4a685a31ba/molecules-29-04889-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验